fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd

Updated on October 16, 2019

Stock/Share Code - SPARC

Sun Pharma Advanced Research Company is in the business of research & development of pharmaceutical products.

Below is the details of SPARC Sun Pharma Advanced Research Company Ltd

Market Cap₹4,191 Cr.
Current Price ₹132.6 as on 22 Oct 19
52 Week High / Low Price₹414 / ₹107
Face Value₹1
Stock P/E
Book Value₹11.3
Dividend Yield0.00 %
ROCE-61.22 %
ROE-61.76 %
Sales Growth (3yrs)4.28 %
SectorMiscellaneous
IndustryMiscellaneous
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company is expected to give good quarter
Cons: Stock is trading at 14.15 times its book value Company has low interest coverage ratio. The company has delivered a poor growth of 1.83% over past five years. Company has a low return on equity of -102.29% for last 3 years.

Sun Pharma Advanced Research Company Ltd Price Chart

Sun Pharma Advanced Research Company Ltd Price Chart

Sun Pharma Advanced Research Company Ltd Peer Comparison in Miscellaneous

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Info Edg.(India) ₹2,397.75 303.10 ₹24,790.43 Cr. 0.30 -₹187.58 Cr. -898.22 15.40 319.74 3.94
2. Gujarat Gas ₹181.7 22.63 ₹12,263.67 Cr. 0.56 ₹233.69 Cr. 92.51 48.13 2614.61 19.13
3. Security & Intel ₹32 22.13 ₹5,553.51 Cr. 0.46 ₹75.02 Cr. 88.21 24.64 2008.40 15.89
4. Team Lease Serv. ₹3,041.4 48.86 ₹4,642.11 Cr. 0.00 ₹18.79 Cr. -13.85 22.51 1251.23 20.35
5. Just Dial ₹625.2 40.55 ₹4,618.92 Cr. 0.00 ₹57.29 Cr. 48.65 13.60 240.17 17.09
6. SPARC ₹4,191.45 Cr. 0.00 -₹94.19 Cr. -46.08 3.03 17.32 -61.22
7. NESCO ₹564.65 20.61 ₹3,717.82 Cr. 0.47 ₹37.9 Cr. 3.02 2.96 78.26 23.16

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sun Pharma Advanced Research Company Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales952342231519201761208517
YOY Sales Growth %120.06%-31.3%1.04%8.89%-83.81%-15.75%-51.71%-28.13%299.41%2.37%322.25%3.03%
Expenses81907510177786581679097112
Material Cost %9.77%37.66%7.24%65.93%6.45%27.03%25.63%17.13%3.34%23.19%3.52%58.55%
Employee Cost %23.5%94.49%47.38%107.87%173.7%127.29%120.96%121.53%32.5%107.44%22.79%130.89%
Operating Profit14-67-34-78-61-58-45-64-5-70-12-95
OPM %14%-290%-81%-333%-400%-300%-224%-379%-8%-354%-14%-549%
Other Income4341125015344
Interest000000000001
Depreciation222222222222
Profit before tax15-66-32-79-63-582-64-3-69-9-94
Tax %0%-0%-0%-0%-0%-0%0%-0%-0%-0%-0%-0%
Net Profit15-66-32-79-63-582-64-3-69-9-94
EPS in Rs0.61-2.67-1.30-3.19-2.53-2.340.10-2.57-0.10-2.72-0.37-3.59
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales37353458298716715616118178183183
Sales Growth %%-6.19%-2.39%70.12%-50.33%201.17%91.37%-6.76%3.56%12.24%-56.77%133.67%%
Expenses4145536599104134191224304321334366
Material Cost %18.31%21.51%19.71%13.16%25.6%10.67%4.8%6.49%11.7%13.9%34.26%6.85%%
Manufacturing Cost %11.51%22.03%22.27%13.62%29.95%11.94%7.42%79.59%81.83%82.62%167.58%89.17%%
Employee Cost %33.13%43.26%58.08%40.05%105%41.88%24.19%29.4%35.09%46.57%128.95%44.33%%
Other Cost %46%42.52%55.48%44.51%180.81%54.72%43.55%7.05%10.52%24.69%79.21%42.38%%
Operating Profit-3-10-19-7-70-1734-35-63-123-243-151-183
OPM %-9%-29%-56%-11%-241%-19%20%-23%-39%-68%-310%-83%-100%
Other Income0-00112103314541416
Interest0000046022001
Depreciation1233334788888
Profit before tax-5-12-22-8-72-2234-40-70-119-197-145-175
Tax %-7%27%-0%-0%-0%-0%12%-0%-0%-0%-0%-0%
Net Profit-5-9-22-8-72-2230-40-70-119-197-145-175
EPS in Rs0.000.000.000.000.000.001.270.000.000.000.000.00-6.78
Dividend Payout %-0%-0%-0%-0%-0%-0%0%-0%-0%-0%-0%-0%

Compounded Sales Growth

  • 10 Years:: 17.93%
  • 5 Years:: 1.83%
  • 3 Years:: 4.28%
  • TTM:: 155.83%

Compounded Profit Growth

  • TTM:: 4.11%

Return on Equity

  • 5 Years:: -90.85%
  • 3 Years:: -102.29%
  • Last Year:: -61.76%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital212121212124242424252526
Equity Capital20.7120.7120.7120.7120.7123.6623.6723.6723.6724.6925.0926.21
Reserves2415-7-15-8785116766133160270
Borrowings022768815456322
Other Liabilities173871668438595999135122101
Trade Payables8.497.2110.9910.3216.2113.0330.0827.6859.3994.45102.4882.92
Total Liabilities6275877886227203163185296309398
Fixed Assets335361636466646770695258
Gross Block37.9459.9770.5375.4579.5984.5786.9896.38106.8277.2867.1780.22
Accumulated Depreciation5.377.139.6512.5215.6519.0222.4929.5836.868.1215.4422.66
CWIP1421101011324
Investments000209760010108211
Other Assets29182411216413296114216146106
Trade receivables24.480.510.52.634.2625.062819.899.1638.917.5610.17
Cash Equivalents0.110.525.355.156.56.726.5617.3412.7570.311.320.68
Loans n Advances4.1216.8318.352.257.4528.3488.8146.3266.5762.9548.7735.96
Other Assets etc0001.082.344.268.1712.9325.2443.6478.5859.4
Total Assets6275877886227203163185296309398

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity-2025132-69-9537-41-44-128-183-172
Profit from operations-3.06-10.24-17.72-5.81-69.37-16.7835.23-34.79-60.75-120.18-242.15-167.21
Working Capital Changes-17.1736.1130.268.140.71-77.919.8-3.7430.4112.8620.48-0.17
Taxes paid-0.16-0.420.1-0.03-0.79-0.65-8.13-2.64-13.87-20.7238.9-4.54
Cash from Investing Activity20-26-12-8-2-994453-13-7-105-102
Fixed Assets Purchased-4.51-26.23-8.18-4.73-4.51-3.6-3.67-8.09-12.33-8.58-32.63-12.95
Fixed Assets Sold0.020.070.030.050.120.040.070.180.520.1614.950.38
Investments purchased000-11.10-173.43-588.58-38.5-16.8-36.95-93.74-93.57
Investments sold0008.65077.39683.6245.2216.8527.5500
Cash from Financing Activity010472194-81-151194224274
Proceeds from Shares00000186.530.540.020.1249.51133.33366.67
Proceeds from Borrowings0.431.292.134.4662.887831.1049000
Repayment of Borrowings00-1.720-1.15-69.97-102.14-0.972.54000
Interest Paid-0.02-0.24-0.13-0.05-0.08-0.51-9.04-0.31-1.5-2.65-0.13-0.1
Net Cash Flow001-10-0-011-760-630

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %-10%-29%-79%-59%-1,034%-20%21%-32%-71%-95%-143%-61%
Debtor Days239551654105614721788220
Inventory Turnover

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sun Pharma Advanced Research Company Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.